⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of DKSH and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
DKSH
↗Zurich, Switzerland
DKSH is a global leader in Market Expansion Services, helping companies grow their business in new or existing markets across Asia Pacific, Europe, and North America. The company provides a comprehensive range of services including sourcing, market insights, marketing and sales, distribution and logistics, and after-sales services.
DKSH operates through four specialized Business Units: Healthcare, Consumer Goods, Performance Materials, and Technology. With over 160 years of history, the company acts as a strategic partner to multinational and Fortune 500 companies, managing the entire value chain for their products.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:-
Industry:Pharmaceuticals
Sub-Industry:Market Expansion Services / Distribution
SIZE & FINANCIALS
Employees:10000+
Revenue:$10B+
Founded:1865
Ownership:public
Status:operating
STOCK
Exchange:SIX Swiss Exchange
Ticker:DKSH
Market Cap:$5.19B
0
CORPORATE STRUCTURE
Key Partnerships:Eli Lilly, Bayer, Thermo Fisher, Reckitt
COMPETITION
Position:Leader
Competitors:Zuellig Pharma, Cardinal Health, AmerisourceBergen, Inchcape
LEADERSHIP
Key Executives:
Marco Gadola - Chairman
Board Members:Marco Gadola, Gabriel Baertschi, Adrian T. Keller
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with DKSH. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.